September is National Recovery Month. When these three words come to mind, they often elicit thoughts of individuals who are recovering from drug or alcohol addiction. Dr. Cashuna (“Shun”) Huddleston, ...
A recent study suggests that semaglutide, typically used for Type 2 diabetes, may significantly reduce the risk of opioid overdoses in patients with opioid use disorder, according to research ...
The US Food and Drug Administration has approved a new drug to treat schizophrenia after over three decades. As stated in a Sept. 26 press release, the new oral drug, Cobenfy, is a twice-daily pill ...